Authors:
Cwynarski, K
Goulding, R
Pocock, C
Dazzi, F
Craddock, C
Kaeda, J
Olavarria, E
Kanfer, E
Apperley, J
Lawler, M
Goldman, JM
Citation: K. Cwynarski et al., Immune haemolytic anaemia following T cell-depleted allogeneic bone marrowtransplantation for chronic myeloid leukaemia: association with leukaemic relapse and treatment with donor lymphocyte infusions, BONE MAR TR, 28(6), 2001, pp. 581-586
Authors:
Craddock, C
Szydlo, RM
Dazzi, F
Olavarria, E
Cwynarski, K
Yong, A
Brookes, P
de la Fuente, J
Kanfer, E
Apperley, JF
Goldman, JM
Citation: C. Craddock et al., Cytomegalovirus seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft-versus-host disease prophylaxis, BR J HAEM, 112(1), 2001, pp. 228-236
Authors:
Olavarria, E
Kanfer, E
Szydlo, R
Kaeda, J
Rezvani, K
Cwynarski, K
Pocock, C
Dazzi, F
Craddock, C
Apperley, JF
Cross, NCP
Goldman, JM
Citation: E. Olavarria et al., Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia, BLOOD, 97(6), 2001, pp. 1560-1565
Authors:
Olavarria, E
Hassan, M
Eades, A
Nilsson, C
Timms, A
Matthews, J
Craddock, C
Kanfer, E
Apperley, J
Goldman, J
Citation: E. Olavarria et al., A phase I/II study of multiple-dose intravenous busulfan as myeloablation prior to stem cell transplantation, LEUKEMIA, 14(11), 2000, pp. 1954-1959
Authors:
Olavarria, E
Parker, S
Craddock, C
Philpott, N
Tiniakou, M
Chase, A
Kanfer, E
Apperley, JF
Goldman, JM
Citation: E. Olavarria et al., Collection of Ph-negative progenitor cells from interferon-responsive patients with chronic myeloid leukemia: effect of granulocyte-colony-stimulating factor mobilization, HAEMATOLOG, 85(6), 2000, pp. 647-652
Authors:
Olavarria, E
Kanfer, E
Szydlo, R
O'Brien, S
Craddock, C
Apperley, J
Goldman, J
Citation: E. Olavarria et al., High-dose busulphan alone as cytoreduction before allogeneic or autologousstem cell transplantation for chronic myeloid leukaemia: a single-centre experience, BR J HAEM, 108(4), 2000, pp. 769-777
Authors:
Dazzi, F
Szydlo, RM
Cross, NCP
Craddock, C
Kaeda, J
Kanfer, E
Cwynarski, K
Olavarria, E
Yong, A
Apperley, JF
Goldman, JM
Citation: F. Dazzi et al., Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia, BLOOD, 96(8), 2000, pp. 2612-2616
Authors:
Dazzi, F
Szydlo, RM
Cross, NCP
Craddock, C
Kaeda, J
Kanfer, E
Cwynarski, K
Olavarria, E
Yong, A
Apperley, JF
Goldman, JM
Citation: F. Dazzi et al., Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia, BLOOD, 96(8), 2000, pp. 2712-2716
Authors:
Dazzi, F
Szydlo, RM
Craddock, C
Cross, NCP
Kaeda, J
Chase, A
Olavarria, E
van Rhee, F
Kanfer, E
Apperley, JF
Goldman, JM
Citation: F. Dazzi et al., Comparison of single-dose and escalating-dose regimens of donor lymphocyteinfusion for relapse after allografting for chronic myeloid leukemia, BLOOD, 95(1), 2000, pp. 67-71
Authors:
Stocchi, R
Szydlo, R
Craddock, C
Kanfer, E
Apperley, JF
Goldman, JM
Ward, KN
Citation: R. Stocchi et al., A comparison of prophylactic vs pre-emptive ganciclovir to prevent cytomegalovirus disease after T-depleted volunteer unrelated donor bone marrow transplantation, BONE MAR TR, 23(7), 1999, pp. 705-709